Category: Drug Development
Asia Drug Development
-
Global & Turkey Cancer Therapeutics Market to 2031
... including immunotherapy and targeted therapies. In response, the Turkish government has launched several initiatives to enhance the development and accessibility of such treatments. One key effort is the Ministry of Health's National Cancer Control Program, ... Read More
-
Global & South Korea Cancer Therapeutics Market to 2031
... approximately 274,488 new cancer cases that year. Thyroid cancer topped the list as the most frequently diagnosed, followed by lung, colorectal, breast, and stomach cancers. This growing cancer burden is fueling a corresponding surge in ... Read More
-
Global & Bangladesh Cancer Therapeutics Market to 2031
... producing generic cancer medications, which helps make treatments more affordable and accessible to a larger segment of patients. However, the market faces challenges including the absence of widespread cancer screening programs, limited availability of advanced ... Read More
-
Global & Malaysia Cancer Therapeutics Market to 2031
... improve patient survival rates, the Ministry of Health established the National Cancer Control Blueprint. Data from the National Cancer Registry (NCR) indicates that approximately 50,000 new cancer cases are diagnosed annually in Malaysia, with breast, ... Read More
-
Global & Singapore Cancer Therapeutics Market to 2031
... one of the top causes of mortality in the country. As global cancer care evolves, Singapore has emerged as a prominent center for oncology drug development, attracting both domestic and international pharmaceutical companies to conduct ... Read More
-
Global & Japan Cancer Therapeutics Market to 2031
... least 500,000 individuals in the country are aged 65 or older. Projections from Japan’s National Institute of Population and Social Security Research estimate that by 2050, 37.7% of the population will fall into this age ... Read More
-
Global & Russia Cancer Therapeutics Market to 2031
... saw over 600,000 new cancer cases in 2023, alongside approximately 300,000 cancer-related deaths. The most common cancers include lung, breast, colorectal, and prostate cancers, with lung cancer posing a major challenge due to high smoking ... Read More
-
Global & Indonesia Cancer Therapeutics Market to 2031
... new cancer cases and nearly 300,000 cancer-related deaths. Factors such as a large population base, tobacco use, poor dietary habits, and environmental pollution are key contributors to the increasing incidence of cancer. In response, the ... Read More
-
Global & Thailand Cancer Therapeutics Market to 2031
... inhibitors like Keytruda (pembrolizumab) and Opdivo (nivolumab) have become more accessible in Thailand, offering promising options for patients with melanoma, non-small cell lung cancer (NSCLC), bladder cancer, and other cancers. These therapies enhance the immune ... Read More
-
Global & Taiwan Cancer Therapeutics Market to 2031
... in managing conditions such as non-small cell lung cancer (NSCLC), melanoma, and head and neck cancers. Additionally, the growing trend toward personalized therapies tailored to patients' genetic profiles has fueled demand for companion diagnostics and ... Read More
-
Global & China Cancer Therapeutics Market to 2031
... diagnoses and 3 million cancer-related deaths were reported in the country in 2020. Alarming statistics from WHO suggest that, on average, seven individuals are diagnosed with cancer every minute in China, and four die from ... Read More
-
Global & India Cancer Therapeutics Market to 2031
... cancer, lung cancer, leukemia, and non-Hodgkin lymphoma are among the most frequently observed types. Specifically, breast cancer accounted for 13.5% (178,361) of all cancer cases and 10.6% (90,408) of cancer-related deaths, with a cumulative risk ... Read More
-
Global & Philippines Cancer Therapeutics Market to 2031
... and the Philippine Health Insurance Corporation (PhilHealth), have significantly contributed to enhancing access to cancer care services and medications. Despite these advancements, challenges persist—particularly the high cost of therapies and limitations within the country’s healthcare ... Read More
-
Global Multiomics Market, By Product & Service (Products, Services), By Type (Single-cell Multiomics, Bulk Multiomics), By Platform (Genomics, Transcriptomics, Proteomics, Metabolomics, Integrated Omics Platforms), By Application (Diagnostics, Drug Discovery and Development, Personalized Medicine, AgriGenomics, Others), By End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Clinical Research Organizations, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... facilitates a deeper understanding of molecular mechanisms, pathways, and networks compared to single-omics approaches. It allows researchers to gain a more complete picture of biological processes and phenotypes. The multiomics market is growing rapidly as ... Read More
-
Rnai Technology Market, By Application (Drug Discovery and Development, Therapeutics, Functional Genomics, Others), By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, CROs & CMOs, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... (siRNAs) or microRNAs (miRNAs). It has emerged as a powerful tool for selective inhibition of gene expression and functional genomics screens. RNAi holds immense potential for developing novel therapeutics by silencing specific disease-causing genes. The ... Read More
-
BRICS Cancer Therapeutics Market Report (2021–2031) by Scope, Segmentation, Dynamics, and Competitive Analysis
... Summary and BRICS Cancer Therapeutics Market Analysis: The cancer therapeutics market in BRICS is experiencing significant growth driven by growing burden of breast and lung cancer and surging investments in oncology research . For instance, ... Read More
-
ASEAN Cancer Therapeutics Market Report (2021–2031) by Scope, Segmentation, Dynamics, and Competitive Analysis
... Summary and ASEAN Cancer Therapeutics Market Analysis: The increasing incidence of cancer—fueled by an aging population; urbanization; and lifestyle changes such as smoking, unhealthy diets, and reduced physical activity—boost the market growth in these countries. ... Read More
-
Asia Pacific Cancer Therapeutics Market Report (2021–2031) by Scope, Segmentation, Dynamics, and Competitive Analysis
... Summary and Asia Pacific Cancer Therapeutics Market Analysis: Cancer rates are escalating in these countries due to the rapidly aging population; increasing life expectancy; and lifestyle changes such as poor diet, smoking, and lack of ... Read More
-
Red Biotechnology Market, By Product Type (Biopharmaceuticals, Biosimilars, Gene Therapy, Tissue Engineering, Cell Therapy), By Application (Drug Discovery & Development, Animal Biotechnology, Environmental Biotechnology, Medical Biotechnology, Industrial Biotechnology, Agricultural Biotechnology, Others), By End User (Pharmaceutical & Biopharmaceutical Companies, Research Institutes, Biotechnology Industry, Hospitals & Diagnostic Centers, Academic Institutions), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)
... the treatment and prevention of diseases. Market Dynamics: Red biotechnology market is driven by several factors. These include the increasing global healthcare needs due to aging populations, rising chronic diseases, and pandemics. Advances in genomics, ... Read More
-
High End Cellomics Market, By Product Type (Instruments, Reagents and Consumables, and Software & Services), By Application (Drug discovery, Cancer Research, Neuroscience, Stem Cell Research and Regenerative Medicine, Personalized Medicine, and Others), By Technology (Microscopy, Flow Cytometry, Single-cell Genomics, Mass Spectrometry, Next Generation Sequencing, and Others), By End User (Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostic Laboratories, Contract Research Organizations, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... for the study of cells at a molecular level. These technologies enable scientists and researchers to analyze cell structure, function, and dynamics, leading to important advancements in various fields such as drug discovery, disease diagnosis, ... Read More
-
DNA Synthesizer Market, By Product Type (Benchtop DNA Synthesizers, Automated DNA Synthesizers), By Application (Gene Synthesis, Oligonucleotide Synthesis, Next-Generation Sequencing (NGS) Library Preparation, Drug Development, Others (DNA labeling, aptamer synthesis, synthetic biology)), By Synthesis Scale (Small-Scale DNA Synthesis, Medium-Scale DNA Synthesis, Large-Scale DNA Synthesis), By End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutions, Contract Research Organizations (CROs), Forensic Laboratories, Others (government organizations, diagnostic laboratories)), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... possible to create DNA from amino acids. In order to create cDNA, reverse transcription of mRNA and protein production both utilize it. The feedback or feed-forward DNA synthesizer is another name for type II. It's ... Read More
-
Oligonucleotide Synthesis Market,By Equipment and Services (Equipment/Synthesizer (Nucleic Acid Synthesizer, Peptide Synthesizer), Reagents, Services, (Oligo Synthesis, Modification, Purification)), By Technology (Column-based, Microarray-based), By Nucleic Acid (DNA, RNA), By Application (Drug Discovery, Therapeutics), By End User (Academic Research Institutes, Diagnostic Laboratories, Pharmaceutical-biotechnology Companies), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)
... Other uses of oligonucleotides include DNA sequencing, DNA microarrays, fluorescence in situ hybridization (FISH), and nucleic acid aptamers. Moreover, many pharmaceutical companies are focusing on developing nucleic acid-based therapeutics due to which the demand of ... Read More
-
Bovine Plasma Market, by Grade (Technical and Standard), by Origin (U.S., Australia, New Zealand, and Others (Brazil, Mexico, etc.)), by Application (Cell Culture Media, Vaccine Production, Drug Discovery, and Others (Forensic Studies, in vitro diagnostics, etc.)), by End User (Biopharmaceutical Industry, Academic & Research Institutes, and Others (Diagnostic Laboratories, Forensic Laboratories, etc.)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2025 - 2032
... free of cells and cellular debris. It is yellow in color due to presence of bilirubin. It is generally collected from the commercial slaughterhouse from cattle. It has wide range of applications in vaccine production, ... Read More
-
Liquid Handling Systems Market, By Type (Electronic Liquid Handling Systems, Automated Liquid Handling Systems, and Manual Liquid Handling Systems), By Product Type (Pipettes, Reagent Dispensers, Liquid Handling Workstations, Burettes, Microplate Washers, and Consumables), By Application (Drug Discovery, Genomics, Clinical Diagnostics, Proteomics, and Others), By End User (Biopharmaceutical Companies, Research Institutes, Hospitals and Diagnostic Laboratories, Others), By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
... like assay development, drug discovery, chemical analysis, and many other areas of research that involve fluids. They enhance productivity by reducing human errors and inconsistencies while ensuring high throughput, accuracy, and reproducibility of experimental results. ... Read More
-
Biomarkers Market, By Product Type (Biomarkers Test Kits, Biomarker Analyzer), By Application (Diagnostic Biomarkers, Monitoring Biomarkers, Drug discovery and development, Predictive biomarkers, Prognostic biomarkers), By Disease Indication (Cancer, Cardiovascular disorders, Neurological Disorder, Infectious Disease, Others (Immunological Disorder, and Autoimmune Disorders among others )), By End User (Hospitals, Research laboratories, Diagnostic laboratories, Research and academic institute), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2025 - 2032
... blood, urine, or soft tissues. Numerous scientific disciplines employ biomarkers. There are 2 types of biomarkers actively used in the market, they are Biomarker test Kits and Biomarker Analyzer. A relatively new set of clinical ... Read More
Research Assistance
